Tag Archives: Qiagen

← Older posts

Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More

Gilead Sciences CEO Daniel O’Day has spoken openly about acquisitions as a way to build up the company’s drug pipeline. This week, it made its biggest buy yet. The $21 billion Immunomedics acquisition brings to Gilead a cancer drug that many analysts project will become a blockbuster seller. Some of those analysts think Gilead might […]

Posted in Boston blog main, Boston top stories, Boulder/Denver blog main, Boulder/Denver top stories, Detroit blog main, Detroit top stories, Europe blog main, Europe top stories, Indiana blog main, Indiana top stories, National, National blog main, National top stories, New York blog main, New York top stories, Philadelphia Blog Main, Philadelphia Top stories, Raleigh-Durham blog main, Raleigh-Durham top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Seattle blog main, Seattle top stories, Texas blog main, Texas top stories, Wisconsin blog main, Wisconsin top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More

Qiagen Juices RNA Extraction Kit Capacity to Feed Coronavirus Test Needs

Dutch molecular diagnostics company Qiagen said Tuesday it would “dramatically” ramp up production of the components needed for the RNA extraction kits used to detect the novel coronavirus in a patient sample. Isolating genetic material from a biological sample is a key step in the testing process, which has not been widespread in the US […]

Posted in Europe blog main, Europe top stories, National, National blog main, National top stories | Tagged , , , , , , , , , , | Comments Off on Qiagen Juices RNA Extraction Kit Capacity to Feed Coronavirus Test Needs

After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

DNA sequencing machine maker Illumina will have to find another way to “read” long pieces of genetic material as well as short stretches, the genomic giant’s bailiwick. Its $1.2 billion proposal to acquire long-read capability by buying rival Pacific Biosciences ended Thursday following challenges from antitrust regulators. The deal foundered about 14 months after the […]

Posted in National blog main, National top stories, San Diego, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories | Tagged , , , , , , , , , , , , | Comments Off on After Antitrust Challenges, Illumina and PacBio Throw in Towel on Merger

ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies

2020 will be a big year for ArcherDX, says its CEO on the heels of raising $55 million to advance its companion diagnostics platform—which is intended to make precision medicine an option for patients in earlier stages of disease. Headquartered in Boulder, CO, the company will use the Series C funds to expand its global […]

Posted in Boulder/Denver, Boulder/Denver blog main, National, National blog main | Tagged , , , , , , , , , | Comments Off on ArcherDX Raises $55M to Help Physicians Pick Best Cancer Therapies

Starting a Medtech Company? Try Skipping Venture Capital, VCs Say

San Antonio — What’s the best way to build a startup? Bootstrap it, raise little or no VC funding, and (ideally) sell it for hundreds of millions—or billions—of dollars, according to two venture capitalists. That’s what they did at least. Andrew Farquharson, now the managing director of InCube Ventures in San Jose, CA, was the chief […]

Posted in National blog main, San Francisco blog main, Texas, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Starting a Medtech Company? Try Skipping Venture Capital, VCs Say

East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More

Most everyone in biotech is on their way to San Francisco this weekend, making their annual trek to the J.P. Morgan Healthcare Conference for a few days of wall-to-wall meetings, schmoozing, and state-of-the-industry pontifications. But rather than get swallowed up by the conference maelstrom, biotechs try to get their big news out ahead of the […]

Posted in Boston, Boston blog main, National blog main, New York blog main, New York top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on East Coast Bio Roundup: NY Startups, Editas, Bonney, C4 & (Much) More

Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test

It may have taken a couple of years, but Exosome Diagnostics has finally raised the money it said it wanted to potentially launch its liquid biopsy-based diagnostic test. Exosome announced today it has closed a $60 million Series B round of funding, money that it is putting toward getting its first oncology products on the […]

Posted in Boston, Boston blog main, National blog main, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off on Exosome Diagnostics Closes $60M Series B for Liquid Biopsy Test

Exosome Diagnostics Garners $60,000,000 Series B Financing Round

Feed Type Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3830b1ce-8276-444a-8c7e-d31d9c6ff7c7 Date 1/7/2016 Company Name Exosome Diagnostics Mailing Address 840 Memorial Drive Cambridge, MA 02139 USA Company Description Exosome Diagnostics, Inc. is focused on commercializing minimally invasive molecular diagnostics using body fluids. Website http://www.exosomedx.com Transaction Type Venture Equity Transaction Amount $60,000,000 Transaction Round Series B Proceeds Purposes Exosome Diagnostics expects to use […]

Posted in Boston, Boston VentureDeal VC | Tagged , , , , , , , | Comments Off on Exosome Diagnostics Garners $60,000,000 Series B Financing Round

Exosome Dx, Aiming to Commercialize “Liquid Biopsies,” Seeks $25M

It’s the moment of truth for any emerging diagnostics firm: the transition from startup to commercial-stage company. Time to convince insurers that you have something worth paying for, and doctors in major hospitals and community practices to change how they practice and incorporate your test. That critical point is where Cambridge, MA-based Exosome Diagnostics finds […]

Posted in Boston, Boston blog main, Boston top stories, National blog main, National top stories, New York blog main, New York top stories, San Diego blog main, San Diego top stories, San Francisco blog main, San Francisco top stories, Texas blog main, Texas top stories | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , | 1 Comment

Data Companies Carve Out Niche In DNA Test Interpretation

For more than a decade researchers have been unleashing a deluge of information about the role of genes in disease, based on automated sequencing of DNA. Genetic tests on individual patients are slowly becoming more common, more detailed, and less costly. But patients won’t benefit if their doctors don’t know what to make of those […]

Posted in Boston, National blog main, San Francisco, San Francisco blog main | Tagged , , , , , , , , , , , , , , , , , , , , , | Comments Off on Data Companies Carve Out Niche In DNA Test Interpretation← Older posts